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Summary
Several transcriptional coactivators have been implicated inmodulating the transcriptional activities of nuclear hormone re-
ceptors in vitro. Potential roles of these cofactors in important physiological processes such as energy homeostasis remain
unknown.We report here that a developmental arrest in interscapular brown fat and defective adaptive thermogenesis occur
in mice lacking both the p160 family transcriptional coactivators SRC-1 and p/CIP due to a failure in induction of selective
PPARg target genes involved in adipogenesis and mitochondrial uncoupling. In the absence of p/CIP and SRC-1, mice
eat more food on both regular chow and a high-fat diet because of decreased blood leptin levels. However, the p/CIP2/2/
SRC-12/2 mice are lean and resistant to high-fat-diet-induced obesity. They exhibit increased basal metabolic rates and
heightened levels of physical activity. Therefore, p/CIP and SRC-1 play critical roles in energy balance by controlling both
energy intake and energy expenditure.Introduction
Nuclear hormone receptors play critical roles in homeostasis,
development, and reproduction. These transcription factors un-
dergo a conformational change upon ligand binding, resulting in
dissociation of receptor bound corepressors and recruitment of
specific coactivator complexes, thus activating transcription of
their target genes (reviewed in Glass and Rosenfeld, 2000;
McKenna et al., 1999). This process involves a numbers of co-
regulatory complexes that are required for regulated gene ex-
pression in vitro. It raises the question of whether unique combi-
nations of coactivators are specifically required for the actions of
individual nuclear receptors and/or whether there is promoter/
enhancer specificity in these requirements in normal develop-
ment and homeostasis.
Among the coactivators important for nuclear receptor func-
tion in vitro are the p160 family of PAS/bHLH factors, often
referred to as SRC-1/NcoA1, T1F2/GRIP1/SRC2, and p/CIP/
AIB1/ACTR/SRC3 (Anzick et al., 1997; Chen et al., 1997; Hong
et al., 1997). These coactivators recruit the CARM1 arginine
methyltransferase (Chen et al., 1999) and the CBP/p300 histone
acetyltransferases (HATs) (Chen et al., 1997; Kamei et al., 1996)
to regulatory regions (promoters/enhancers) of target genes.
Other coactivators, including the TRAP/DRIP/ARC complex,
the P/CAF complex, BRG1 complexes, and Tip60 as well as
other tissue- or receptor-specific factors such as PGC1a (Puig-
server et al., 1998), are also implicated in nuclear receptor acti-
vation events (reviewed in Chakravarti et al., 1996). Detailed
kinetic studies of promoter occupancy (Metivier et al., 2003;
Shang et al., 2000) have suggested that there is an ordered turn-
over of complexes after stimulation, accounting for the ability of
many cofactors to be recruited in response to a ligand.While it isCELL METABOLISM 3, 111–122, FEBRUARY 2006 ª2006 ELSEVIER INCclear that most of the identified coactivators are important for
nuclear-hormone-receptor transcriptional activities in vitro, spe-
cific developmental and physiological roles of the coactivators
for the nuclear-hormone-receptor pathways in vivo remain to
be clearly defined.
Nuclear hormone receptors play critical roles in energy ho-
meostasis. Energy balance consists of energy intake and energy
expenditure. Energy intake is from food, while energy expendi-
ture involves adaptive thermogenesis, physical activity, and
basal metabolism. Two functionally distinct adipose tissue
types, brown and white fat, are crucial for energy balance in ro-
dents. White fat develops postnatally in mice and stores triglyc-
erides as an energy reserve; it also secretes adiponectin, free
fatty acids, IL6, leptin, RBP4, resistin, TNFa, and visfatin, which
are involved in insulin sensitivity, inflammation, and appetite
control. Brown fat develops during embryogenesis and is fully
functional in newborn mice. This tissue uncouples b-oxidation
in mitochondria from ATP synthesis to generate heat in a cold
environment or on a high-fat diet, a process known as adaptive
thermogenesis. Nuclear hormone receptors, such as peroxi-
some proliferator-activated receptor g (PPARg), are critical for
both white and brown fat development, as shown by genetic
studies (Barak et al., 1999; Kubota et al., 1999; Rosen et al.,
1999). A PPARg coactivator, PGC1a, is critical for b-oxidation
in brown fat in addition to its important roles in skeletal-muscle
fiber-type switch and fasting responses in liver (reviewed in
Puigserver and Spiegelman, 2003). PGC1a functions as an
adaptor in vitro to recruit SRC-1 to enhance the transcriptional
activity of nuclear hormone receptors such as PPARg (Puig-
server et al., 1999). Recent studies with TIF2/GRIP12/2 and
SRC-12/2 single-knockout mice have demonstrated that loss
of TIF2 enhances the function and development of brown. DOI 10.1016/j.cmet.2006.01.002 111
A R T I C L Eadipose tissue, whereas SRC-1 knockout mice have reduced
thermogenic capacity (Picard et al., 2002). It was therefore pro-
posed that TIF2 and SRC-1 compete for binding to PPARg and
activate transcription of its target genes with different potencies
(Picard et al., 2002). In vivo PPARg target genes include those
encoding adipogenic and fat-storage proteins, such as aP2,
LPL, and CD36, and uncoupling proteins UCP1 and UCP2
(UCP2 is an indirect target), which are crucial for heat generation
in brown fat. On the other hand, PPARd controls b-oxidation (fat
burning) by activating transcription of UCP1 and enzymes in-
volved in b-oxidation such as acyl-CoA oxidase (AOX1) (Wang
et al., 2003).
In this study, we demonstrate that the p/CIP and SRC-1 coac-
tivators are crucial for energy balance. Combined loss of p/CIP
and SRC-1 function leads to a temporally specific block in
brown fat development, with no lipid storage in the tissue, de-
creased uncoupling-protein expression, and defective adaptive
thermogenesis. Loss of p/CIP and SRC-1 also leads to in-
creased food intake on both regular chow and a high-fat diet.
However, the double-knockout mice remain lean and resistant
to high-fat-diet-induced obesity because of increased basal
metabolic rates and enhanced physical activity.
Results
Developmental arrest of brown adipose tissue
in p/CIP2/2/SRC-12/2 double knockout mice
Previous studies of p/CIP2/2 single-knockout mice showed
that the IGF1 signaling pathway was defective, resulting in a
somatic-growth defect (Wang et al., 2000; Xu et al., 2000).
SRC-12/2 mice have been reported to exhibit mild phenotypes
in themammary gland and ovary, probably as a result of a partial
deficiency in responsiveness of the estrogen-receptor pathway
(Xu et al., 1998). To fully elucidate the physiological roles of
these cofactors, we crossed p/CIP2/2 mice (Wang et al.,
2000) withSRC-12/2mice (Qi et al., 1999) and generated double
p/CIP+/2/SRC-1+/2 heterozygotes, which were then crossed to
generate double-homozygous p/CIP2/2/SRC-12/2mice. About
70% of double-knockout mice died neonatally, generally at 2–3
weeks of age. We are currently investigating the cause of death.
The body weight of the surviving double-homozygous mice was
50 to 70% of their wild-type littermates, similar to that observed
for p/CIP2/2 mice (Wang et al., 2000; Xu et al., 2000). Thus, al-
though deletion of SRC-1 in the p/CIP null background did not
cause a further decrease in somatic growth, there was an obvi-
ous gene-dosage effect for p/CIP and SRC-1 on early postnatal
survival.
Upon examination of the newborn p/CIP2/2/SRC-12/2 dou-
ble-knockoutmice, we found a consistent difference in the inter-
scapular brown adipose tissue, obvious to the naked eye, with
much more prominent brown adipose tissue in the wild-type lit-
termates and single knockouts than in double-knockout pups.
The percentage of wet weight of the dissected brown fat to
body weight from double-knockout mice was about 50% of
that of their littermate controls (Figure 1A). The weight differ-
ences in brown fat appear to reflect diminished lipid storage
(see below). On standard histological analysis of paraffin sec-
tions, we observed an arrest of brown-adipose-tissue develop-
ment at an immature stage, with no lipid droplets evident in dou-
ble-knockout mice (Figure 1C), whereas both single knockouts112showed normal lipid droplets like wild-type littermates (arrows
in Figure 1C). Frozen sections of interscapular brown fat from
wild-type and single-knockout newborn mice exhibited typical
abundant oil red O (lipid) staining, whereas that of the double-
knockout mice exhibited no lipid staining (no red staining,
Figure 1D). Therefore, combined deletion of the p/CIP and
SRC-1 loci led to a developmental arrest in brown adipose tis-
sue at a stage prior to lipid storage.
To begin to investigate the molecular mechanisms underlying
the defects in brown-adipose-tissue development, we gener-
ated preadipocyte cell lines from interscapular brown adipose
tissue of newborn mice according to published protocols (Klein
et al., 1999). Upon induction to differentiate in vitro, these im-
mortalized cell lines derived from p/CIP heterozygotes in either
SRC-1 wild-type or null background (p/CIP+/2/SRC-1+/+,
p/CIP+/2/SRC-12/2) mice differentiated into adipocytes (oil red
O staining in Figure 1B). However, the preadipocyte cell line
from p/CIP2/2/SRC-12/2 mice failed to differentiate (identical
to vector control in Figure 1B). Therefore, brown-adipose-tissue
preadipocyte cell lines from the double-knockout mutants ex-
hibited a developmental arrest similar to brown adipose tissue
in vivo. The failure to accumulate lipid in brown fat is exhibited
by both the cell lines in culture and brown fat in vivo, and this de-
fect is cell autonomous (see below).
We stably re-expressed p/CIP, SRC-1, or both genes in the
p/CIP2/2/SRC-12/2 cell line using retroviral constructs. The
control vector alone had no effect on the developmental arrest
(Figure 1B). When both p/CIP and SRC-1 genes were re-
expressed in the p/CIP2/2/SRC-12/2 cell line, differentiation of
these cells was efficiently rescued (Figure 1B), consistent with
the fact that the defect is cell autonomous. When the PPARg li-
gand rosiglitazone was added for the last 4 days of induction,
the reconstituted preadipocyte lines differentiated much more
efficiently (greater oil red O staining in Figure 1B). However, no
differentiation was observed in the vector-reconstituted cell
lines derived from p/CIP2/2/SRC-12/2 mice, with or without
rosiglitazone (Figure 1B, last column).
A constitutively active form of PPARg, PPARg-VP16, in which
full-length PPARg is fused to the VP16 activation domain (Saez
et al., 2004), was also used to test whether it could rescue the
adipogenesis phenotype in vitro. PPARg-VP16 has been dem-
onstrated to activate expression of PPARg target genes by us-
ing a different set of coactivators based on interaction with
a specific subunit of the mediator complex (Yang et al., 2004).
The PPARg-VP16 fusion gene was expressed stably in the
p/CIP2/2/SRC-12/2 preadipocyte cell line to test whether re-
duced PPARg pathway activity was responsible for the develop-
mental defect. Upon induction of differentiation, the PPARg-
VP16-reconstituted cell line exhibited abundant lipid storage,
indicative of rescue of the developmental block of the p/CIP2/2/
SRC-12/2 preadipocyte cell line (Figure 1B, last row). Addition
of the PPARg agonist rosiglitazone for the last 4 days of induc-
tion further enhanced adipogenesis (Figure 1B, last row), imply-
ing that this ligand might either dissociate the corepressors or
stimulate recruitment of additional coactivators to full-length
PPARg-VP16. Stable expression of wild-type PPARg did not
rescue lipid storage (Figure 1B). The successful rescue by
constitutively active PPARg-VP16 but not wild-type PPARg
indicates that PPARg and its direct targets represent the key
regulated pathway requiring p/CIP and SRC-1 for correct devel-
opmental progression of brown adipose tissue.CELL METABOLISM : FEBRUARY 2006
p/CIP and SRC-1 control energy balanceFigure 1. Brown adipose tissue from p/CIP2/2/SRC-12/2 double-knockout mice is arrested at an immature stage without any lipid storage
A) Interscapular brown adipose tissue was isolated from newborn mice and weighed. Five mice of each genotype were measured. The amount of brown adipose tissue
(BAT) as a percentage of total body weight is presented. *** indicates that the double knockouts have significantly less brown adipose tissue than wild-type and p/CIP2/2
andSRC-12/2 single knockouts (P1 = 2.49473 1027 betweenwild-type and DKO, P2 = 1.88093 1025 between p/CIP2/2 and p/CIP2/2/SRC-12/2, and P3 = 7.60563 1027
for SRC-12/2 and p/CIP2/2/SRC-12/2).
B) Cell-autonomous defect in brown-adipose-tissue development is rescued by a constitutively active PPARg (PPARg-VP16) in a preadipocyte cell line derived from
p/CIP2/2/SRC-12/2mice. Preadipocyte cell lines were prepared from interscapular brown adipose tissue of newborn mice. The preadipocyte cell lines were reconstituted
with retroviral constructs expressing indicated genes or vector control and were then induced to differentiate into mature brown adipocytes with or without rosiglitazone.
Differentiated cells were fixed, permeabilized, and stained with oil red O.
C)Hematoxylin and eosin (H&E) staining of paraffin sections of brown adipose tissue of newborn mice. Red arrows in the top left panel point to lipid droplets; no lipid drop-
lets are evident in p/CIP2/2/SRC-12/2 BAT.
D) The newborn brown adipose tissue was fixed in formalin and frozen-sectioned. Standard oil red O staining (red) was then performed on these sections. The blue nuclear
staining was from Mayer’s hematoxylin.Decreased expression of a subset of PPARg target genes
Brown adipose tissue dissipates energy by uncoupling b-oxida-
tion from ATP synthesis. Mitochondrial uncoupling proteinsCELL METABOLISM : FEBRUARY 2006(UCP1–3, mainly UCP1) transport protons back across the inner
membrane of mitochondria to generate heat instead of ATP (re-
viewed in Lowell and Spiegelman, 2000). An enhancer element113
A R T I C L EFigure 2. Expression of selective PPARg target genes is reduced in brown adipose tissue of p/CIP2/2/SRC-12/2 mice
A and B) Total RNAs were isolated from interscapular brown adipose tissue of newborn mice, and 6 mg was loaded for each genotype of mice, each lane representing one
mouse. Northern blot analyses were then performed sequentially with the indicated probes. All the results were from overnight exposure except that of UCP1, which was
from 1 hr exposure.2.5 kb upstream of the UCP1 promoter controls tissue-specific,
high-level expression of UCP1 in brown fat. This enhancer
contains canonical binding sites for PPARg aswell as for the ret-
inoic-acid receptor (RAR) and thyroid hormone receptor (re-
viewed in Lowell and Spiegelman, 2000). Northern blot analyses
were used to assess the effects of deleting the p/CIP and SRC-1
coactivators on expression of UCPs and of genes regulating adi-
pogenesis and lipid storage in the newborn brown adipose tis-
sue (Figures 2A and 2B). There was a 5- to 6-fold decrease in
UCP1 RNA (normalized with b-actin RNA for loading; Figure 2A),
which is normally expressed at very high levels, and a 2-fold de-
crease inUCP2mRNA levels in the brown adipose tissue of new
born p/CIP2/2/SRC-12/2 double-knockout mice, whereas in the
SRC-1 or p/CIP single knockouts, we observed no obvious
changes in expression of these genes compared to that in
wild-type mice (Figure 2A). UCP3 was not detected in newborn
brown adipose tissue.
The levels of several other PPARg target genes expressed in
brown adipose tissue, including CD36, which encodes free-
fatty-acid transporters, and AOX1, a target gene of both PPARg
(Mueller et al., 2002) and PPARd (Wang et al., 2003), were also
slightly decreased in p/CIP2/2/SRC-12/2 mice (Figure 2B).
PPARgmRNA levelswereactually increased inbrownadipose tis-
sue ofp/CIP2/2/SRC-12/2mice,which suggests that the block of
target-gene transcription might occur at the level of PPARg-
dependent gene-activation events (Figure 2B). However, for other
PPARg target genes, including LPL (lipoprotein lipase) and aP2,114there was little or no detectable change in mRNA levels in the
brown adipose tissue of the double-gene-knockout mice (Figures
2A and 2B). Expression of a mitochondrial marker, COXII (cyto-
chromeC oxidase subunit II), was normal in brown adipose tissue
of the double knockouts (Figure 2A). Together, these data re-
vealed that the p/CIP and SRC-1 coactivators regulate cohorts
of genes required for PPARg-dependent brown-adipose-tissue
development, includinga subsetof genes that regulate fat storage
and, most strikingly, adaptive thermogenesis.
Mechanism of selective downregulation of a subset
of PPARg target genes in brown fat
To further explore the molecular mechanism (or mechanisms) of
in vivo downregulation of selective PPARg target genes, we per-
formed chromatin immunoprecipitation (ChIP) assays on brown
adipose tissue from newborn p/CIP2/2/SRC-12/2 mice. As
shown in Figure 2, UCP1 expression was greatly decreased in
p/CIP2/2/SRC-12/2 brown adipose tissue, whereas expression
of genes such as AOX1 was less affected, and the levels of LPL
and aP2 transcripts in vivowere essentially unaffected (Figure 2).
ChIP analyses were performed on PPARg-dependent target
genes, including UPC1, AOX1, and aP2, assessing the binding
of PPARg, representative coactivators (p/CAF, TIF2, Tip60,
and CBP/p300), and corepressors (NCoR and RIP140). These
ChIP studies revealed that recruitment of these factors to aP2
was similar in brown fat of double knockouts and littermate con-
trols (Figure 3A). However, ChIP assays on the UCP1 enhancer,Figure 3. Increased binding of corepressors and de-
creased binding of PPARg to the promoter/enhancer
of affected target genes
A and B) Interscapular brown adipose tissue from
newborn individual micewas isolated, and chromatin
immunoprecipitation (ChIP) assays were performed
with the indicated antibodies. The left and right
panels represent ChIP assays on theUCP1 enhancer
carried out on different groups ofmice. The upstream
enhancer (22.5 kb from the transcriptional starting
site) of UCP1 and the promoter of aP2 were studied
in (A) and (B), and the promoter of AOX1was also an-
alyzed in (B) (the enhancer and promoters contain
PPARg binding sites).
C) Immunoblot analyses with the indicated anti-
bodies were performed with interscapular brown ad-
ipose tissue of newborn mice on the same mem-
brane.CELL METABOLISM : FEBRUARY 2006
p/CIP and SRC-1 control energy balanceFigure 4. Adaptive thermogenesis is defective in the p/CIP2/2/SRC-12/2 mice
A) Two-month-old male mice (five for each genotype) were put in a cold room (4ºC) for 6 hr with free access to water and regular chow. Their body temperatures were
measured in the cold room. Control temperatures were taken at room temperature for the same group of mice. *** indicates significantly lower body temperature for
p/CIP2/2/SRC-12/2 mice in a cold environment (P1 = 0.00011, P2 = 0.00047, and P3 = 0.00059).
B) Two-month-old male mice (five for each genotype) were fed a high-fat diet (HFD) (43% fat) for 10 weeks. Their body temperature was measured at room temperature
after 10 weeks on the diet.
C) Total RNAs from brown fat of mice with this diet were used for Northern blot analyses with the indicated probes.
D) Paraffin sections of interscapular brown adipose tissue from high-fat-diet-fed adult mice were stained with H&E.critical for expression of UCP1, revealed markedly decreased
binding of PPARg in p/CIP2/2/SRC-12/2 mice compared to
that in littermate controls (Figure 3A; in order to demonstrate
that the differences in cofactor binding were consistent among
different groups of mice, the left and right panels show analysis
of UCP1 enhancer binding in two different experiments from
different groups of mice), despite the presence of a slightly
elevated PPARg protein level (Figure 3C). Significantly more
NCoR corepressor was bound to the UCP1 enhancer region,
which contains PPARg, thyroid hormone receptor (TR), and ret-
inoic-acid receptor (RAR) binding sites, in p/CIP2/2/SRC-12/2
brown adipose tissue than in brown adipose tissue of littermate
controls, whereas coactivators, such as CBP, were bound at
lower levels (Figure 3A). Decreased binding of TIF2/GRIP1 to
the UCP1 enhancer was also noted in the absence of p/CIP
and SRC-1, whereas an increased level of RIP140, which is re-
ported to be a ligand-dependent corepressor for nuclear recep-
tors (Lee and Wei, 1999), was recruited to the UCP1 enhancer
(Figure 3B). On the other hand, recruitment of RIP140 to the
aP2 promoter did not change, even though the protein level of
RIP140 increased in the absence of p/CIP and SRC-1 (Fig-
ure 3C). Recent genetic data have demonstrated that RIP140 re-
presses UCP1 gene expression in vivo (Leonardsson et al.,
2004). Thus, the loss of the p/CIP and SRC-1 coactivators leads
to a failure to stimulate expression of selective PPARg target
genes due to decreased binding of PPARg to its responsive
motifs and enhanced recruitment of inhibitory cofactors, such
as NCoR and RIP140, which serve to downregulate gene tran-
scription.CELL METABOLISM : FEBRUARY 2006Defective adaptive thermogenesis in p/CIP2/2/SRC-12/2
double-knockout mice
To test their adaptive thermogenic response to a cold environ-
ment, we exposed adult male p/CIP2/2/SRC-12/2 double-
knockout mice (2 months old) with their littermates to 4ºC for
6 hr with free access to regular chow and water. The body tem-
perature of double-knockout mice in this cold environment was
significantly lower than that of p/CIP2/2 or SRC-12/2 single-
knockout mice or that of wild-type littermates (Figure 4A). There
was no significant difference in the body temperature of the dif-
ferent genotypes of mice kept at room temperature on a regular
diet. p/CIP2/2/SRC2/2 double-knockout mice were then fed a
high-fat diet (43% fat) for 10 weeks. We measured body tem-
perature of the mice on the diet after 10 weeks and found the
double-knockout mice had significantly lower body temperature
on this high-fat diet (Figure 4B). Northern blot analyses showed
decreased expression of UCP1 in the brown fat of p/CIP2/2/
SRC2/2 double-knockout mice compared to littermate controls
with the same high-fat diet (Figure 4C). Brown fat from wild-type
and p/CIP2/2 and SRC-12/2 single-knockout mice fed a high-
fat diet exhibited abundant lipid droplets (for both p/CIP2/2
and SRC-12/2 single-knockout mice, white-fat-like lipid storage
was observed in brown fat as exhibited in Figure 4D), whereas
that of double-knockout mice fed the same high-fat diet ex-
hibitedminimal lipid accumulation (Figure 4D). This adult pheno-
type is consistent with the phenotype observed in newborn
brown fat, even though only 30% of double-knockout mutants
survived. Studies with TIF2/GRIP12/2 knockout mice have
shown that TIF2/GRIP1 represses brown fat function in vivo115
A R T I C L EFigure 5. The p/CIP2/2/SRC-12/2 mice eat more
and remain lean
A and B) The double-knockout mice have less white
fat. Three-month-old male mice were sacrificed (five
for each genotype), and their white fat pads were dis-
sected and weighed. The relative amounts of white
fat (per body weight) are presented.
C) The double-knockout mice eat much more (food
intake per body weight) than their littermates. Five
double-knockout mice and their littermate controls
were measured, and data are presented as weekly
food consumption per body weight.
D) Serum levels of leptin were measured with ELISA
assays (presented as ng/ml). The experiments here
used five mice of each genotype.and enhanceswhite fat development (Picard et al., 2002). On the
other hand, loss of SRC-1 impairs adaptive thermogenesis with
white fat infiltration into brown fat (Picard et al., 2002).
We observed a similar phenotype in the brown fat of p/CIP2/2
single-knockout mice (Figure 4D). The p/CIP2/2/SRC-12/2
double-knockout mice on a high-fat diet, on the other hand,
exhibited a significantly reduced lipid storage andUCP1 expres-
sion in brown fat.
The p/CIP2/2/SRC-12/2 double-knockout mice eat more
but remain lean
We went on to examine white fat in adult p/CIP2/2/SRC-12/2
double-knockout mice. We found that the relative weight of
white fat pads (compared to body weight) of the double-knock-
out mice was significantly less than that of their single-knockout
and wild-type littermates (Figures 5A and 5B). In contrast, the
relative weights of organs such as liver, kidney, spleen, and tes-
tis were similar in all genotypes (data not shown). Therefore, the
double null mice were lean when fed regular chow. We were cu-
rious whether this lean phenotype was the result of decreased
food intake. To our surprise, we observed that the double mu-
tants actually ate significantly more regular chow (per body
weight) than p/CIP or SRC-1 single knockouts or wild-type litter-
mates did (Figure 5C). Because the double-knockout mice ate
significantly more, we measured blood leptin levels in these
mice. Leptin levels of the double-knockout mice were about
20%–30% of those of wild-type littermates and were signifi-
cantly lower than those of the single-knockout mice (Figure 5D).116We believe that the double mutants eat more because of lower
blood leptin levels.
The p/CIP2/2/SRC-12/2 mice have a higher metabolic
rate and are more active
Although the double-knockout mice ate more, they remained
lean on regular chow. Where did the extra energy go in these
mice? Obviously, the additional calories were not stored as tri-
glycerides in white fat since these double-knockout mice were
lean, suggesting an increase in energy expenditure. We there-
fore monitored these mice with metabolic cages for 48 hr to de-
termine their basal metabolic rates and physical activity. We
again observed more food intake (per body weight) for the dou-
ble-knockout mice fed regular powdered chow in these cages
(data not shown). The double-knockout mice exhibited sig-
nificantly higher basal metabolic rates than those of single-
knockout and wild-type littermates (Figures 6A and 6C, oxygen
uptake). The double-knockout mice were also about two times
more active than their littermate controls, based on ambulatory
movements (Figures 6B and 6D). We conclude that double-
knockout mice had increased energy expenditure because of
a higher metabolic rate and increased physical activity.
The p/CIP2/2/SRC-12/2 double-knockout mice
are resistant to high-fat-diet-induced obesity
We challenged the adult double-knockout mice (2 months old)
with a high-fat diet (43% fat) for 10 weeks. The wild-type and
single-knockout mice gained 20%–30% body weight on thisCELL METABOLISM : FEBRUARY 2006
p/CIP and SRC-1 control energy balanceFigure 6. The double-knockout mice have higher
metabolic rates and are more active
Three-month-old mice (five for each genotype) were
housed in metabolic cages individually for 48 hr with
free access to a regular powdered chow and drinking
water.
A) A representative oxygen consumption graph for
the two nights and the second day of the monitoring
from a single litter of mice (a double-knockout mouse
with its littermate controls), with the first day allowing
the mice to acclimate to the cage environment.
B) Ambulatory (walking) movements of the represen-
tative litter of mice for the same period of time.
C) Total oxygen consumption (per body weight) for
the five double-knockout mice and their littermates
for the duration of the experiments (48 hr).
D) Average ambulatory movements by the five
double-knockout mice and their littermates for the
duration of the experiments (48 hr).diet, whereas the double-knockout mice gained much less
weight (Figure 7A) despite significantly more high-fat diet con-
sumption (per body weight) (Figure 7B). We reasoned that this
increased food intake of the double-knockout mice was be-
cause of decreased levels of leptin. Indeed, the level of leptinCELL METABOLISM : FEBRUARY 2006mRNA in white fat was much lower in the double-knockout
mice than in littermate controls with this high-fat diet (Figure 7F).
The blood levels of leptin of the double-knockout mice were also
much lower than those of single-knockout and wild-type litter-
mates (data not shown). The relative weight of white fat pads117
A R T I C L EFigure 7. The double-knockout mice are resistant to high-fat-diet-induced obesity
A) Two-month-old mice were challenged with a high-fat diet (43% fat) for 10 weeks (five for each genotype). The increases in body weight are presented as a percentage of
initial weight. The data from this figure are all from the same group of mice on high-fat diet for 10 weeks.
B) Food intake on the high-fat diet was measured weekly and is presented here as intake per body weight (the same mice as in [A], with data presented as weekly food
consumption per body weight).
C) The double-knockout mice have decreased total cholesterols in their blood on the high-fat diet (the same group of mice as in [A]; data presented as mg/dl).
D) Reduced total blood triglyceride levels in the double-knockout mice (mg/dl).
E) Histological studies of white fat from mice on the high-fat diet after 10 weeks on the high-fat diet.
F and G) Northern blot analyses with total RNAs isolated from white fat (F) and liver (G) after 10 weeks on the high-fat diet.of the double-knockout mice (per body weight) was significantly
less than that of single knockouts and wild-type littermates on
this diet (data not shown). Standard histological studies showed
that white adipocytes from the double-knockout mice were
resistant to high-fat-diet-induced hypertrophy, in contrast to
those of wild-type and single knockouts (Figure 7E). The
double-knockout mice had comparable free-fatty-acid levels118(data not shown) but significantly lower levels of total triglycer-
ides and cholesterols than single-knockout and wild-type litter-
mates (Figures 7C and 7D).
To investigate the mechanism of resistance to high-fat-diet-
induced obesity, we examined expression of genes whose
products are involved in adipogenesis and lipogenesis. We
observed significantly reduced expression of stearoyl CoACELL METABOLISM : FEBRUARY 2006
p/CIP and SRC-1 control energy balancedesaturase 1 (SCD1) and acetyl CoA carboxylase 1 (ACC1)
mRNAs in white fat and of SCD1 in the liver of the double-knock-
outmice compared to single-knockout andwild-type littermates
(Figures 7F and 7G). ACC1 is an enzyme essential for fatty-acid
synthesis; it converts acetyl CoA to malonyl CoA. SCD1, mainly
expressed in fat and liver, is important for triglyceride and cho-
lesterol synthesis; it desaturates monosaturated fatty acids.
Both ACC1 and SCD1 are lipogenic enzymes. The observed re-
duction in expression of these key enzymes required for fatty-
acid and triglycerides synthesis may explain why the double-
knockout mice generated here had phenotypes similar to those
of SCD1 knockouts, which are lean and resistant to high-fat-
diet-induced obesity (Ntambi et al., 2002). SCD1 knockouts
also eat more, are more active, and have higher basal metabolic
rates (Dobrzyn and Ntambi, 2005). We reasoned that the dra-
matically reduced SCD1 expression in white fat and liver might
account for the lean and obesity-resistant phenotype we ob-
served for the double-knockout mice. Although there is a
PPAR-responsive site in the promoter region of the SCD1
gene (Miller and Ntambi, 1996), previous studies showed that
the phenotypes of SCD1 knockout mice are independent of
the PPARa pathway (Miyazaki et al., 2004). Interestingly, com-
prehensive mRNA profiling data show that the expression of
both SCD1 and ACC1 is increased in response to a PPARg li-
gand (GW1929) in insulin-responsive tissues in vivo (Way
et al., 2001). Therefore, the p/CIP and SRC-1 coactivators
may enhance SCD1 expression through the PPARg pathway,
and the lack of these two coactivators may directly lead to re-
duction of SCD1 expression. However, it is worth noting that
not all of the lipogenic genes were downregulated and that
some PPARg targets, such as LPL and aP2, were not dramati-
cally decreased in the white fat of the double-knockout mice.
Discussion
In this study, we have generated a mutant mouse line lacking
both the p/CIP and SRC-1 p160 coactivators. We have ob-
served important physiological roles of these coactivators in
both energy intake and energy expenditure. With respect to
brown-fat-related energy expenditure, we have demonstrated
that two of the p160 coactivators (p/CIP and SRC-1) act to se-
lectively control expression of genes involved in brown-
adipose-tissue development causing an arrest in development
at an immature stage, resulting in a lack of both lipid storage
in the tissue and induction of the genes required for normal
adaptive thermogenesis (such as UCP1 and UCP2). This results
in a decrease in energy expenditure in the brown fat of the dou-
ble-knockout mice. Themolecular basis of these events is that a
subset of PPARg-dependent genes require p/CIP and SRC-1 for
activation, while others do not, indicating promoter/enhancer-
specific distinctions in coactivator requirements. Our studies in-
dicate that the lipid-storage defect in p/CIP2/2/SRC-12/2 brown
fat is cell autonomous and can be recapitulated in vitro in differ-
entiation assays of preadipocyte cell lines derived from double-
knockout mice. Induction of some gene targets in the brown-fat
developmental program, such as LPL and aP2, remained essen-
tially intact in the p/CIP2/2/SRC-12/2 brown adipose tissue in
vivo, while other PPARg gene targets were no longer fully in-
duced (e.g., AOX1). Genes critical for adaptive thermogenesis,
including UCP1, were most severely affected in vivo. Therefore,
brown fat in p/CIP2/2/SRC-12/2 mice ultimately containedCELL METABOLISM : FEBRUARY 2006neither the fuel (lipid storage) nor enough molecular apparatus
(uncoupling proteins, mainly UCP1) to generate sufficient heat,
leading to defective adaptive thermogenesis when challenged
in a cold environment and with a high-fat diet. The phenotype
of the p/CIP2/2/SRC-12/2 mice differs from that of UCP1
knockout mice, which exhibit muchmore abundant lipid storage
than their littermate controls as UCP1 knockout mice cannot
burn off fat through b-oxidation because of the lack of UCP1.
p/CIP2/2/SRC-12/2 double-knockout mice lack not only
UCP1 expression but also lipid storage, and the adaptive ther-
mogenesis phenotype results from these two defects.
The transcriptional coactivator PGC1a has been shown to in-
teract with SRC-1 to enhance transcription of its target genes
in vitro (Puigserver et al., 1999). Recently, it has been reported
that the PGC1a knockout mice exhibit defective adaptive
energy responses (Lin et al., 2004). The p/CIP2/2/SRC-12/2
double-knockout mice we have generated here exhibit many
but not all of the phenotypes observed in the PGC1a knockout
mice, such as deficient adaptive thermogenesis, leanness, hy-
peractivity, and resistance to high-fat-diet-induced obesity.
The similarity in phenotypes suggests that PGC1a and p160 co-
activators (p/CIP and SRC-1) may interact functionally and per-
haps physically in vivo. However, there are differences between
the p/CIP2/2/SRC-12/2 double-knockout and PGC1a knockout
mice. For instance, both lipid storage and UCP1 expression are
significantly reduced in the brown fat of the p/CIP2/2/SRC-12/2
double-knockout mice, whereas the brown fat in PGC1a knock-
out mice has increased lipid storage (Lin et al., 2004). It will be
interesting to investigate whether there is any striatal degenera-
tion in the p/CIP2/2/SRC-12/2 double-knockout mice, which is
evident in the PGC1a knockout mice (Lin et al., 2004).
From our results, we suggest that the third p160 coactivator
family member, TIF2/GRIP1, which suppresses development
and function of brown fat in vivo (Picard et al., 2002), cannot
compensate for the obligatory roles for p/CIP and SRC-1 in ac-
tivation of a specific subset of the genes that constitute an es-
sential part of the PPARg pathway in brown fat. The finding
that the expression of AOX1 gene, which is a required enzyme
for fat burning in brown adipose tissue, was downregulated
also indicated that the failure to store lipid in the brown fat of
p/CIP2/2/SRC-12/2 mice did not reflect excessive b-oxidation
of free fatty acids. Because free fatty acids are ligands for
PPARg, feeding mice a high-fat diet stimulates PPARg targets
in vivo, and the brown adipose tissue of wild-type and single-
knockout mice shows an increase in fat storage. However, con-
sistent with the defect in the PPARg-dependent lipid-storage
pathway in the brown adipose tissue of p/CIP2/2/SRC-12/2
mice, little fat accumulated in the brown fat of p/CIP2/2/
SRC-12/2 adult mice fed a high-fat diet. Furthermore, these
p/CIP2/2/SRC-12/2 mice also exhibited a significantly lower
UCP1 expression on this high-fat diet.
Our functional analysis of p/CIP and SRC-1 in brown-
adipose-tissue development has revealed that coactivator re-
quirements for PPARg actions are promoter/enhancer specific.
Thus, on some PPARg gene targets (such as aP2 and LPL),
these cofactors are not required, while on others, they are of
quantitative importance (such as AOX1), and on yet another
group of PPARg gene targets (e.g., UCP1), they have proven
to be essential. Consistent with the observed alterations in gene
expression, ChIP data revealed that, in the absence of p/CIP
and SRC-1, there was increased recruitment of corepressors119
A R T I C L Esuch as NCoR and RIP140 complexes on the UCP1 gene en-
hancer and an ineffective recruitment of specific coactivators
such as CBP. The UCP1 enhancer contains binding sites for
PPARg, TR, and RAR, and these binding sites are too close
for us to distinguish in the ChIP assays whether the enhanced
recruitment of RIP140 andNCoR is to the PPARg site or the sites
for TR and RAR. It has been documented that these corepres-
sors indeed bind to TR and RAR to repress transcription.
There was also diminished PPARg recruitment on affected
gene targets, particularly UCP1, in vivo. Thus, directly or indi-
rectly, effective PPARg binding requires the actions of p/CIP
and SRC-1 on the same subset of PPARg gene targets down-
regulated in brown fat of double-knockout mice. The absence
of p/CIP/SRC-1 and the consequent disordered exchange of
cofactor complexes apparently result in a failure to maintain
robust PPARg binding to the UCP1 promoter. Even with the di-
minished recruitment of PPARg, the ligand-dependent core-
pressor RIP140, an LXXLL-containing cofactor (Christian et al.,
2004), becomes more robustly recruited to the UCP1 enhancer
in the absence of SRC-1/p/CIP. This observation is correlated
with the genetic demonstration that RIP140 repressesUCP1 ex-
pression in vivo (Leonardsson et al., 2004). The dynamic compe-
tition between factors such as p/CIP/SRC-1 and NCoR/RIP140
mayprovideanadditional componentof thepromoter/enhancer-
specific actions of PPARg.
The double-knockout mice are lean, with a significantly re-
duced white fat mass, and are resistant to obesity on both reg-
ular chow and a high-fat diet, even though they eat much more
food than their single-knockout and wild-type littermates. How
then do these the double-knockout mice remain lean? Where
does the extra energy go? Is it stored as fat in the liver? We
did not observe an increased fat content in the livers of the dou-
ble-knockout mice, even on a high-fat diet (data not shown). In
part, the reduction in white fat mass may be due to decreased
adipogenesis (as well as reduced lipogenesis—see below) be-
cause analysis of mouse embryonic fibroblasts (MEFs) as an
in vitro model of white fat differentiation demonstrated that
MEFs from the double-knockout mice exhibited significantly de-
creased adipogenesis compared to wild-type MEFs (data not
shown). In addition, we discovered that the double-knockout
mice have a higher basal metabolic rate and are more active,
and we believe that the increased energy expenditure is largely
responsible for the lean phenotype. The increased basal meta-
bolic rates and activities suggested that the thyroid-hormone-
receptor pathway might be deregulated in the double-knockout
mice. Indeed, there is partial thyroid hormone resistance in the
SRC-1 single knockouts (Sadow et al., 2003; Weiss et al.,
1999). Therefore, we measured total T3 and T4 levels in the
blood of double-knockout mice and their littermate controls.
Even though we did observe elevated T3 and T4 levels in the
SRC-1 knockouts as reported previously (Weiss et al., 1999),
we found normal T3 and T4 levels in double-knockout mice, the
p/CIP single knockouts, and the wild-type controls (data not
shown). Thus, changes in the thyroid-hormone-receptor path-
way seemunlikely to contribute to the phenotypes of the double-
knockoutmice, but we cannot completely rule out this possibility
without measuring tissue-specific deiodinase activity.
We have discovered that two key genes, leptin andSCD1, dis-
play reduced expression levels in the double-knockout mice. At
this stage, we do not know whether the effect on the leptin level
is direct or indirect, and we will investigate this effect further in120the future. Dramatically decreased leptin levels usually lead to
obesity because of increased food consumption (Cohen and
Friedman, 2004). However, the double-knockout mice remain
lean with greater appetite and food intake. We suggest that sig-
nificantly decreased expression of SCD1 in both white fat and
liver leads to increased basal metabolic rates and activities
and reduced lipogenesis in the double-knockout mice, similar
to the phenotypes of the SCD1 knockout mice (Dobrzyn and
Ntambi, 2005; Ntambi et al., 2002). We suggest that p/CIP and
SRC-1 may exert direct effects on SCD1 expression by interact-
ing with PPARg or d (more likely the former because of the lipo-
genic activity of PPARg) at the PPAR-responsive site (Miller and
Ntambi, 1996) in the promoter of the SCD1 gene.
We have created a unique mouse model that, despite in-
creased energy intake and decreased adaptive thermogenesis,
remains lean and resistant to high-fat-diet-induced obesity. In
our society, the obesity epidemic we are facing today results
mostly from excessive consumption of high-calorie food cou-
pled with insufficient energy expenditure. Our results suggest
that the p160 coactivators p/CIP and SRC-1 play critical roles
in energy balance and could be potential therapeutic targets
for obesity: disrupted function or reduced expression of p/CIP
and SRC-1 might reduce high-fat-food-induced obesity despite
increased energy intake.
Experimental Procedures
Animals
The p/CIP2/2 and SRC-12/2 single-knockout mice were generated as
described previously (Qi et al., 1999; Wang et al., 2000). p/CIP2/2 and
SRC-12/2 single-knockout mice of C57Bl/6 and Sv129 mixed background
were crossed to generate double-heterozygous mice. These double-hetero-
zygous mice were then crossed to generate double-homozygous knockout
mice (DKO). To obtain a larger number of DKO, mice that were p/CIP+/2 het-
erozygous and SRC-12/2 homozygous were crossed to have a 25% chance
of obtaining a DKO. Genotyping of the knockout mice was performed with
the following four pairs of primers in genomic PCR reactions: for p/CIP
wild-type allele PC1 primer 50-AGTGTCCTCCTCAACATCAGG-30, PC2
primer 50-CTTCTTAGGACTCAGCTGCTCC-30 (homozygous p/CIP2/2 null
mutants produce no PCR product with this primer pair); to detect p/CIP-
targeted allele, the primer from p/CIP gene CP4100 50-CCTTGCTGGCTAAT
CTGACC-30 and the primer from neomycin gene Neo1500 50-CCTTCTATCG
CCTTCTTGACG-30 were used. For SRC-1 wild-type allele SRC1 primer
50-CCACCATCCAACAACAACATGG-30, SRC2 primer 50-AGCACTGTTGTC
GCTGTTGTC-30 (homozygous SRC-1 null mutants produce no PCR product
with this primer pair); to detect the SRC-1 targeted allele, the primer from
SRC-1 gene SC1168 50-CCGAATAAATCCCTCAGTCAATCCTGG -30 and
the primer from neomycin gene Neo1500 50-CCTTCTATCGCCTTCTTGA
CG-30 were used. All PCR reactions were performed first by denaturing at
94ºC for 5 min and then 35 cycles of 94ºC for 30 s, 55ºC for 30 s, and 72ºC
for 45 s followed by extension at 72ºC for 7 min. PCR genotyping results
were confirmed by genomic Southern Blot analyses (data not shown). All an-
imals weremaintained and handled according to NIHGuidelines. For cold-in-
duced adaptive thermogenesis tests, 2-month-old male littermate mice were
put in a cold room for 6 hr with free access to water and regular chow. Body
temperature was measured in the cold room with a thermometer from Sen-
sortek Inc., Physitemp BAT-12, equipped with a mouse rectal probe. For
the control condition, mice were kept at room temperature before and during
measurements. A high-fat diet (43% fat, TD97268) from Harland Teklad was
fed to 2-month-old male littermate mice for 10 weeks. Body temperature was
thenmeasured for thesemice at room temperature before sacrifice for brown
adipose tissue analyses.
Metabolic studies
Three-month-old mice (five for each genotype) were housed and monitored
individually in a metabolic cage (Columbia Instruments) with free access toCELL METABOLISM : FEBRUARY 2006
p/CIP and SRC-1 control energy balancea regular powdered chow and drinking water for 48 hr. Each cage was mon-
itored for metabolic parameters (including food and oxygen consumptions
and animal activity) at 36 min intervals throughout the 48 hr period. Total ox-
ygen consumption was calculated as accumulated oxygen uptake (for the
duration of the experiments) for each mouse divided by its body weight.
Mouse movements were presented as the average of ambulatory move-
ments (per min) for all the mice of each genotype for the 48 hr duration. Rep-
resentative graphs of oxygen uptake and ambulatory movements were from
one litter of mice for the two nights and second day of the experiments.
Measurements of blood parameters
Three-month-old mice were fasted overnight, and blood samples were col-
lected by retro-orbital bleeding methods. Sera were prepared and used for
measurements. Levels of leptin were determined with Linco Research’s
ELISA kits. Free fatty acids and cholesterols were measured with Wako
Chemicals’ kits. Total triglycerides were determined with a Thermo Electron
Corporation’s Total Triglycerides kit.
Hematoxylin-and-eosin analyses and oil red O staining for lipid
Standard hematoxylin and eosin (H&E) staining was performed on 5 mm par-
affin sections of interscapular brown adipose tissue. Oil red O staining for
lipid was performed on 10 mm frozen brown fat tissue sections. In vitro differ-
entiated cells were fixed for 20 min in buffered formalin and stained with oil
red O for 15 min.
Establishment of preadipocyte cell lines from brown fat
and rescue of adipogenesis
Interscapular brown adipose tissue was dissected from newborn mice,
weighed, and digested and single-cell culture was prepared as described
(Klein et al., 1999). These cultured primary cells were then infected with a ret-
rovirus expressing the SV40 T antigen to immortalize the cells. After 4 weeks’
selection of G418, cloneswere picked for each genotype. All the following re-
constitutions were performed on a single clone of the DKO cells. To differen-
tiate these preadipocytes in vitro, confluent cells were treated with 20 nM in-
sulin, 0.5 mM dexamethasone, 0.5 mM IBMX, 0.125 mM indomethacin, and
1 nM T3 for 24 hr. The cells were then switched to the medium with only in-
sulin and T3 for 6 more days. For some experiments, 1 mM rosiglitazone was
added for the last 4 days of treatment together with insulin and T3. Full-length
p/CIP and SRC-1 cDNAs were cloned in to pMSCV-hph and pBabe-puro
retroviral vectors, respectively, to generate expressing retroviruses. The
pBabe-puro retrovirus expressing PPARg-VP16 was as described (Saez
et al., 2004). Infected preadipocyte cell lines were subjected to 2 to 4 weeks
of hygromycin or puromycin selection; pooled clones were used for differen-
tiation experiments.
Antibodies and immunoblotting protocol
Interscapular brown adipose tissue from newborn mice was homogenized in
SDS-PAGE loading buffer and boiled before loading onto the gel for electro-
phoresis. Proteins were then transferred onto nitrocellulose membrane, and
immunoblotting with ECL was performed according tomanufacturer’s proto-
cols (Amersham). A rabbit polyclonal antibody against NCoR was used in the
ChIP assays. The antibody against a-tubulin was from Sigma. The rest of
the antibodies were from Santa Cruz Biotechnology.
Northern blot analyses
Total RNAs from cell lines and interscapular brown adipose tissue were iso-
lated with QIAGEN’s RNeasy Mini Kit according to the manufacturer’s proto-
col. Northern blot analyses were performed according to Current Protocols in
Molecular Biology. Briefly, 6 mg RNAs were denatured in formamide and
formaldehyde and separated on 1.2% denaturing agarose gel with 3% form-
aldehyde and 0.5 mg/ml ethidium bromide. Pictures of the agarose gel were
then taken, and RNAs were transferred to Hybond-N+ nylon membrane with
203 SSC by blotting overnight. Denatured 32P-labeled cDNA probes were
then hybridized with the membranes in Stratagene’s Quik-Hyb solution at
65ºC for 1 hr. The membranes were then washed once with 23 SSC and
0.1% SDS and once with 0.53 SSC and 0.1% SDS, each at room tempera-
ture for 15min, and 0.1%SSC and 0.1%SDS at 65ºC for 15min. Membranes
were then exposed to X-ray film at280ºC overnight. After stripping of probes
with boiling 0.5% SDS, subsequent hybridizations were performed on the
same membranes with indicated probes.CELL METABOLISM : FEBRUARY 2006Chromatin immunoprecipitation (ChIP) assays
For the ChIP assays, interscapular brown adipose tissue from newborn mice
was dissected out and pressed through Falcon’s 40 mm cell strainer to gen-
erate single-cell suspensions with PBS. Cells were washed twice with PBS
and crosslinked with 1% formaldehyde for 5 hr at room temperature. Cross-
linked cells were then washed with PBS twice, resuspended in 0.3 ml of lysis
buffer (50 mM Tris-HCl [pH 8.1], 1% SDS, 10 mM EDTA, protease inhibitors),
and sonicated three times for 10 s followed by centrifugation for 10 min at
4ºC. The supernatant was diluted 1:10 to make the soluble chromatin solu-
tion with average size of sheared fragments about 300–1000 bp. One-twen-
tieth of diluted chromatin solutions was used as input, and the rest was incu-
bated with specific antibodies overnight at 4ºC followed by addition of
protein A Sepharose and salmon sperm DNA and incubated for 1 hr. Immu-
noprecipitates were eluted three times with 1%SDS, 0.1MNaHCO3. Eluates
were pooled and heated at 65ºC for 6 hr to reverse the formaldehyde cross-
linking. DNA fragments were purified with a QIAquick spin kit (QIAGEN). For
PCR, 1 ml from a 50 ml DNA extraction solution was usedwith 30 cycles of am-
plification and the following promoter/enhancer-specific primers. UCP1-1:
GTGAAGCTTGCTGTCACTCCTC; UCP1-2: TGAAATTCTCGCTCAAGGA
GGC. aP2-1: GAGCCATTAAGACTAAGAATCTC; aP2-2: CTGGCAATGTAC
ATGGACTTAGAG. AOX1-1: TCTCACCACAGTGTCCCCGGAA; AOX1-2:
AAGCTCCGCAGGACCAGGTCCTT. The amplified promoter/enhancer re-
gions contain identified PPARg binding sites.
Statistical analyses
All results are presented as means6 SEM. A nonpaired Student’s t test was
used for these analyses. A difference is considered significant as the follow-
ing: *p < 0.05, **p < 0.005, and ***p < 0.0005.
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